Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.55 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.55 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.55 |
| ▸ | F3 | P13726 | 2/20 | 0.54 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.53 |
| ▸ | GSK3B | P49841 | 2/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.50 |
| ▸ | GPR183 | P32249 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 3/20 | 0.48 |
| ▸ | RAB9A | P51151 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14375119 | 1.00 | CYP1A2 (0.55) | CYP1A2CYP2D6CYP1A1CYP1B1F3 | |
| SCHEMBL18374565 | 0.85 | CYP24A1 (0.46) | CYP1A2CYP2D6CYP1A1CYP1B1F3 | |
| SCHEMBL23285244 | 0.84 | MAOB (0.56) | CYP1A2CYP2D6GPR183NPC1RAB9A | |
| SCHEMBL19188581 | 0.83 | CYP1A2 (0.48) | CYP1A2CYP2D6CYP1A1CYP1B1F3 | |
| SCHEMBL22416556 | 0.82 | TYR (0.49) | CYP1A2CYP2D6F3GSK3BHDAC3 | |
| SCHEMBL18374566 | 0.82 | TBXAS1 (0.49) | CYP1A2CYP2D6GAANPC1RAB9A | |
| SCHEMBL4715046 | 0.81 | MAOB (0.56) | CYP1A2CYP2D6GPR183MEN1MAPT | |
| SCHEMBL5201692 | 0.81 | CYP24A1 (0.54) | CYP1A2CYP2D6CYP1A1CYP1B1F3 | |
| SCHEMBL1186024 | 0.81 | CYP24A1 (0.54) | CYP1A2CYP2D6CYP1A1CYP1B1F3 | |
| SCHEMBL14375126 | 0.81 | TRIM24 (0.47) | CYP1A2CYP1A1CYP1B1GAANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119968415-A | Ultraviolet curable composition and use thereof | 陶氏东丽株式会社 | 2025-05-09 | — | — | CN | disclosed |
| CN-107540617-B | Imidazole compound, metal surface treatment liquid, metal surface treatment method, and method for producing laminate | 东京应化工业株式会社 | 2020-12-18 | — | — | CN | disclosed |
| CN-106687447-B | Imidazole compound, metal surface treatment liquid, metal surface treatment method, and method for producing laminate | 东京应化工业株式会社 | 2020-06-02 | — | — | CN | disclosed |
| EP-2883868-B1 | CRYSTAL CONTAINING UNSATURATED CARBOXYLIC ACID AMIDE COMPOUND AND METHOD FOR PRODUCING SAME | DAICEL CORP (JP) | 2019-10-09 | — | — | EP | disclosed |
| EP-3514145-A1 | IMIDAZOLE COMPOUND, METAL SURFACE TREATMENT LIQUID, METAL SURFACE TREATMENT METHOD, AND LAMINATE PRODUCTION METHOD | Tokyo Ohka Kogyo Co., Ltd. (JP) | 2019-07-24 | — | — | EP | disclosed |
| US-10336708-B2 | Imidazole compound, metal surface treatment liquid, metal surface treatment method, and laminate production method | TOKYO OHKA KOGYO CO., LTD. (JP) | 2019-07-02 | — | — | US | disclosed |
| EP-3184511-B1 | IMIDAZOLE COMPOUND, METAL SURFACE TREATMENT LIQUID, METAL SURFACE TREATMENT METHOD, AND LAMINATE PRODUCTION METHOD | TOKYO OHKA KOGYO CO LTD (JP) | 2019-03-20 | — | — | EP | disclosed |
| US-20170247334-A1 | IMIDAZOLE COMPOUND, METAL SURFACE TREATMENT LIQUID, METAL SURFACE TREATMENT METHOD, AND LAMINATE PRODUCTION METHOD | TOKYO OHKA KOGYO CO., LTD. (JP) | 2017-08-31 | — | — | US | disclosed |
| EP-3184511-A1 | IMIDAZOLE COMPOUND, METAL SURFACE TREATMENT LIQUID, METAL SURFACE TREATMENT METHOD, AND LAMINATE PRODUCTION METHOD | Tokyo Ohka Kogyo Co., Ltd. (JP) | 2017-06-28 | — | — | EP | disclosed |
| US-9206138-B2 | Crystal containing unsaturated carboxylic acid amide compound and method for producing same | DAICEL CORPORATION (JP) | 2015-12-08 | — | — | US | disclosed |
| US-20150299135-A1 | CRYSTAL CONTAINING UNSATURATED CARBOXYLIC ACID AMIDE COMPOUND AND METHOD FOR PRODUCING SAME | DAICEL CORPORATION (JP) | 2015-10-22 | — | — | US | disclosed |
| EP-2883869-A1 | CRYSTALS CONTAINING UNSATURATED CARBOXYLIC ACID AMIDE COMPOUND AND METHOD FOR PRODUCING SAME | Daicel Corporation (JP) | 2015-06-17 | — | — | EP | disclosed |
| EP-2883868-A1 | CRYSTAL CONTAINING UNSATURATED CARBOXYLIC ACID AMIDE COMPOUND AND METHOD FOR PRODUCING SAME | Daicel Corporation (JP) | 2015-06-17 | — | — | EP | disclosed |
| US-20150158820-A1 | CRYSTALS CONTAINING UNSATURATED CARBOXYLIC ACID AMIDE COMPOUND AND METHOD FOR PRODUCING SAME | DAICEL CORPORATION (JP) | 2015-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10336708-B2 | Imidazole compound, metal surface treatment liquid, metal surface treatment method, and laminate production method | FASN, SLC27A1, SLC27A2 | CYP1A2 662/4885CYP2D6 1660/4885CYP1A1 1718/4885 |
| US-20170247334-A1 | IMIDAZOLE COMPOUND, METAL SURFACE TREATMENT LIQUID, METAL SURFACE TREATMENT METHOD, AND LAMINATE PRODUCTION METHOD | FASN, SLC27A1, SLC27A2 | CYP1A2 662/4885CYP2D6 1660/4885CYP1A1 1718/4885 |
| US-20150299135-A1 | CRYSTAL CONTAINING UNSATURATED CARBOXYLIC ACID AMIDE COMPOUND AND METHOD FOR PRODUCING SAME | ACSL1, FFAR2, FADS2 | CYP1A2 192/4885CYP2D6 1046/4885CYP1A1 588/4885 |
| US-20150158820-A1 | CRYSTALS CONTAINING UNSATURATED CARBOXYLIC ACID AMIDE COMPOUND AND METHOD FOR PRODUCING SAME | FFAR1, FFAR2, FFAR3 | CYP1A2 162/4885CYP2D6 610/4885CYP1A1 236/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.